Despite guideline recommendations, many hypertensive patients remain on monotherapy longer than needed. This delay, known as clinical inertia, increases the risk of cardiovascular complications, especially among high risk patients.
Despite guideline recommendations, many hypertensive patients remain on monotherapy longer than needed. This delay, known as clinical inertia, increases the risk of cardiovascular complications, especially among high risk patients.